MedPath
NMPA Approval

Ipratropium Bromide Solution for Inhalation

国药准字H20213485

June 16, 2021

Drug Information

吸入用异丙托溴铵溶液

吸入用溶液剂

2ml:0.25mg(按C20H30BrNO3计)

化学药品

June 16, 2021

Company Information

Applicant Company

武汉市东湖新技术开发区高新大道858号生物医药园A7展示中心

Manufacturing Company

四川省成都市蒲江县鹤山街道工业南路67号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吸入用异丙托溴铵溶液 - NMPA 批准文号 | MedPath